• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18595 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Ward rounds - a health technology assessment focused on production of knowledge
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2006     VA Technology Assessment Program (VATAP) Wait times for primary hip and knee replacement surgery
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2013     HAYES, Inc. VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2008     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Voriconazole
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for acute coronary syndrome
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2011     HAYES, Inc. von Willebrand Factor (VWF) gene testing for von Willebrand Disease (VWD)
2014     HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2005     The Swedish Council on Health Technology Assessment (SBU) Volume and quality - a preliminary study
2013     NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Volanesorsen - familial chylomicronemia syndrome – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Voke 0.45mg inhaler for smoking cessation – first line
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Voice controlled arthroscopic pump
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2004     Adelaide Health Technology Assessment (AHTA) Vocera (R) wireless communication
2014     HAYES, Inc. Vocal fold steroid injection for treatment of dysphonia
2012     Malaysian Health Technology Assessment (MaHTAS) VNUS® Radiofrequency Ablation (RFA) for varicose vein
2005     Adelaide Health Technology Assessment (AHTA) VNS Therapy(TM) System for the treatment of chronic or recurrent treatment-resistant depression in adults
2007     Adelaide Health Technology Assessment (AHTA) VNS therapy system for the treatment of depression
2008     HAYES, Inc. ViziLite Plus with TBlue (Zila Inc.) as an adjunct to conventional oral mucosal screening for high-risk patients
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2009     NIHR Health Technology Assessment programme Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing for northern populations: clinical and cost-effectiveness and guidelines
2020     Swiss Federal Office of Public Health (FOPH) Vitamin D testing
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infection: individual patient data meta-analysis of randomised controlled trials
2014     NIHR Health Technology Assessment programme Vitamin D supplementation in pregnancy: a systematic review
2012     HAYES, Inc. Vitamin D supplementation in patients with osteoporosis
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Vitamin D supplementation in patients with active or latent tuberculosis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D supplementation in long-term care residents: clinical evidence and guidelines
2012     HAYES, Inc. Vitamin D supplementation and risk of fractures, falls, and bone loss
2014     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes (update)
2009     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes
2012     HAYES, Inc. Vitamin D and breast cancer
2012     Malaysian Health Technology Assessment (MaHTAS) Vitamin C Injection for Cosmetic
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin B12 testing in the general population: clinical and cost-effectiveness and guidelines
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2014     HAYES, Inc. Vitagel surgical hemostat (Stryker Corporation) for perioperative hemostasis
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne (TM) therapy for the treatment of age-related macular degeneration
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne
2009     VA Technology Assessment Program (VATAP) Visual problems in traumatic brain injury
2003     VA Technology Assessment Program (VATAP) Visual field testing in VA compensation and pension examinations
2006     HAYES, Inc. Visual evoked potentials in the diagnosis/prognosis of multiple sclerosis
2006     HAYES, Inc. Visual evoked potentials for diagnosing and monitoring glaucoma
2001     Medical Services Advisory Committee (MSAC) Visual electrodiagnosis
2002     HAYES, Inc. Vision therapy for visual dysfunctions and dyslexia and other reading disabilities
2012     HAYES, Inc. Vision therapy for dyslexia and other reading and learning disabilities
2013     HAYES, Inc. Vision therapy for convergence insufficiency and accommodative dysfunction in children
2011     HAYES, Inc. Vision therapy for accommodative and vergence dysfunction
2003     Institute for Clinical Systems Improvement (ICSI) Vision therapy
2004     Agency for Healthcare Research and Quality (AHRQ) Vision rehabilitation services
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Viscosupplementation for the treatment of osteoarthritis of the knee: clinical effectiveness and guidelines
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Viscosupplementation for the treatment of osteoarthritis of the knee
2015     NIHR Health Technology Assessment programme Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis
2003     HAYES, Inc. Viscocanalostomy for treatment of glaucoma
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Virtual simulation in radiotherapy and 3D conformational radiation therapy
2020     Health Technology Wales (HTW) Virtual reality therapy for the management of procedure-related pain
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Virtual reality exposure therapy for adults with post-traumatic stress disorder: a review of the clinical effectiveness
2004     NIHR Health Technology Assessment programme Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations
2003     Adelaide Health Technology Assessment (AHTA) Virtual colonoscopy: non-invasive CT scanning technique for screening patients with possible bowel disease
2000     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Virtual colonoscopy in screening for colorectal cancer
2003     HAYES, Inc. Virtual colonoscopy (computed tomography colonography)
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Virtual colonoscopy (computed tomography colonography)
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Virtual colonoscopy
2002     Medical Services Advisory Committee (MSAC) Virtual colonoscopy
2017     NIHR Health Technology Assessment programme Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation
2003     Adelaide Health Technology Assessment (AHTA) Virtual bronchoscopy: non-invasive CT scanning technique for screening patients with possible tracheobronchial disease or obstruction
2014     HAYES, Inc. Virtual bronchoscopic navigation for evaluation of peripheral pulmonary lesions
2005     National Institute for Clinical Excellence (NICE) Violence: the short-term management of disturbed/violent behaviour in in-patient psychiatric settings and emergency departments
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vinorelbine (Navelbine Oral®)
2010     NIHR Health Technology Assessment programme Vinflunine for the second line treatment of transitional cell carcinoma of the urothelial tract
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) with capecitabine for advanced breast cancer
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) monotherapy for advanced breast cancer
2009     NIHR Horizon Scanning Centre (NIHR HSC) Vinflunine (Javlor) for transitional cell carcinoma of the urothelial tract - second line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2015     NIHR Horizon Scanning Centre (NIHR HSC) Vincristine liposomal (Marqibo) for relapsed or refractory acute lymphoblastic leukaemia – third line
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets